GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Institutional Ownership

Intelgenx Technologies (FRA:0IL) Institutional Ownership : 0.05% (As of Jun. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intelgenx Technologies's institutional ownership is 0.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intelgenx Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intelgenx Technologies's Float Percentage Of Total Shares Outstanding is 37.33%.


Intelgenx Technologies Institutional Ownership Historical Data

The historical data trend for Intelgenx Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Institutional Ownership Chart

Intelgenx Technologies Historical Data

The historical data trend for Intelgenx Technologies can be seen below:

2019-11-30 2019-12-31 2020-01-31 2020-02-29 2020-03-31 2020-04-30 2020-05-31 2020-06-30 2020-07-31 2020-08-31
Institutional Ownership 0.11 0.11 0.11 0.09 0.09 0.09 0.09 0.05 0.05 0.05

Intelgenx Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Intelgenx Technologies (FRA:0IL) Business Description

Traded in Other Exchanges
Address
6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2
Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies (FRA:0IL) Headlines

No Headlines